TRANSPERFECT GLOBAL, INC.
NEW YORK, NY

, a division of TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced the release of the latest version of GlobalLink Connect for Drupal 8. The solution is designed to help streamline the process of launching and maintaining multilingual content in Drupal by automating manual tasks related to content export and import. The new release offers a vendor management dashboard to centralize translations across the enterprise in one, easy-to-access location. – TransPerfect, the world’s largest provider of language services and technologies for global business, today announced that it has been chosen by Air Corsica, the Mediterranean island of Corsica’s premier air carrier, to support the launch and ongoing maintenance of a new English version of its French-language site. Using customized workflow technology that integrated with Air Corsica’s existing instance of Drupal, GlobalLink Connect simplified the launch and ongoing maintenance of the company’s English-language site by automatically routing new content to TransPerfect's production teams for translation, review, and final placement. All localized text was returned to Drupal—ready to launch. Dan O’Sullivan, Vice President of TransPerfect and head of the company’s specialized travel group, remarked, “With a proven track record of success operating in Corsica and throughout France, Air Corsica is now taking the logical next step as they aim to expand their success abroad. We are proud to have been chosen to help in this very exciting stage of their journey as they build new relationships with English-speaking flyers.” – TransPerfect, the world's largest provider of language and technology solutions for global business, today announced that Co-Founder and Co-CEO Phil Shawe has been invited to deliver a keynote address for the upcoming GALA Language of Business Conference, held March 13-16 in Boston. GALA is a non-profit industry group for translation and localization organizations and is noted for its role in establishing and furthering knowledge, standards, and communities that benefit the industry worldwide. Its members include translation and localization service providers, translation technology developers, globalization teams at multinational enterprises, universities, and consultants. Phil Shawe commented, "It's a significant honor to be asked by GALA to deliver this keynote. Coming from such a respected industry group, I am eager to contribute by sharing thoughts and experiences from 25 years in the language business. Putting my small role aside, I know the conference as a whole will be thought-provoking, enriching, and energizing. Since inception, GALA has always done an outstanding job of advancing important conversation topics in our industry and facilitating knowledge-share among its prestigious member base—for that I am extremely grateful." , a leading provider of services and technologies to support clinical trials and product development for the biopharmaceutical industry, today announced the release of myTI, the company’s ground-breaking mobile application that enables real-time eTMF access and functionality for study teams on the go. myTI is a mobile extension of Trial Interactive, TransPerfect’s award-winning cloud-based e-clinical technology designed by clinical professionals for clinical professionals to simplify management of product development, from study start-up to commercialization.  myTI offers significant benefits to Trial Interactive users by placing key eTMF functionality at the fingertips of study teams no matter where they are. By taking these study processes mobile, including secure document capture, query resolution, and task management, myTI enables users to maximize TMF health and keep studies moving at all times. Document Detection, Capture, and Submission “By enabling a move away from archaic paper TMF management, mobile document capture and upload at investigative sites is a huge step forward in product development and for simplifying the significant project management and CRA challenges involved with bringing treatments to market,” said Michael Smyth, General Manager of TransPerfect Life Sciences Solutions. “myTI will equip study teams with on-the-go access to eTMF materials, which will cut lengthy upload timelines and allow filing with near real-time availability, helping to expedite overall timelines and ensuring TMF inspection readiness.” TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact , a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that ARCA Biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.   ARCA Biopharma is a Colorado-based biopharmaceutical company that focuses on developing genetically targeted therapies for cardiovascular diseases. They initially selected TransPerfect’s Trial Interactive eTMF to support a Phase 2 trial conducted across 50 sites, and will be using the multitenant, cloud-based solution to move all trials to a paperless environment.